跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
STENAC EFFERVESCENT TABLETS 600MG - HSA Drug Approval Details
Approvals
/
HSA
/
STENAC EFFERVESCENT TABLETS 600MG
Approved
THERAPEUTIC
STENAC EFFERVESCENT TABLETS 600MG
SYNMOSA BIOPHARMA CORPORATION, SYNMOSA PLANT
🇸🇬 Health Sciences Authority
Approval Date
Mar 29, 2017
Approval ID
41dae7265394cf92
Company
SYNMOSA BIOPHARMA CORPORATION, SYNMOSA PLANT
Type
Therapeutic
Approval Details
Approval Id
41dae7265394cf92
Drug Name
STENAC EFFERVESCENT TABLETS 600MG
Product Name
STENAC EFFERVESCENT TABLETS 600MG
Approval Number
SIN15201P
Approval Date
2017-03-29
Registrant
SEA PHARMA CONSULTANCY PTE LTD
Licence Holder
SEA PHARMA CONSULTANCY PTE LTD
Drug Type
Therapeutic
Forensic Classification
Pharmacy Only
Dosage Form
TABLET, EFFERVESCENT
Route Of Administration
ORAL
Atc Code
R05CB01
Atc Item Name
acetylcysteine
Pharma Manufacturer Name
SEA PHARMA CONSULTANCY PTE. LTD.
Company Detail Path
/organization/sea-pharma-consultancy-pte-ltd
Active Ingredients
ACETYLCYSTEINE
600MG
ACETYLCYSTEINE
600 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 29, 2017
Approval ID
41dae7265394cf92
Type
Therapeutic
Back to HSA Approvals